OPINION: California’s doldrums continue

Citing the recent closure of San Diego based pharmaceutical company Amylin by Bristol-Myers Squibb Michael Rosen of the Union Tribune points out that even companies based in tax and regulation heavy states like New York don’t want to do business in California.

Click Here to read the article.